Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Stereotactic cranial radiosurgery

Clark C Chen, MD, PhD
Paul H Chapman, MD
Jay S Loeffler, MD
Section Editor
Patrick Y Wen, MD
Deputy Editor
Michael E Ross, MD


The potential utility of ionizing radiation to treat cancer was recognized shortly after the discovery of X-rays, which can cause extensive damage to DNA.

Prior to the development of stereotactic techniques, radiation was delivered to the cancer and a significant volume of surrounding normal tissue. Therapeutic efficacy was based upon the increased DNA-repair capacity of normal cells compared with tumor cells following radiation exposure. The total dose of radiation was delivered in small fractions over a period of weeks to allow normal tissue to preferentially recover or heal itself between doses compared with the tumor so that the cumulative damage to tumor cells was much greater. This fractionated approach is known as radiation therapy (RT) (figure 1).

Major advances in stereotactic localization, noninvasive neuroimaging, and radiation physics made it possible to selectively irradiate a sharply defined target, largely sparing the surrounding normal tissue. This approach, called stereotactic radiosurgery (SRS), is achieved by focusing multiple radiation beams on the tumor tissue from different directions (figure 1).

The biologic differences between fractionated RT and SRS and the technology of administering SRS are reviewed here. The applications of SRS for various tumors (both malignant and nonmalignant) are discussed under separate headings. Similarly the potential complications of cranial SRS and the application of SRS to extracranial sites are discussed separately. (See "Radiation therapy techniques in cancer treatment", section on 'Stereotactic RT techniques' and "Acute complications of cranial irradiation" and "Delayed complications of cranial irradiation".)


Fractionated (conventional) RT — Fractionated or conventional radiation therapy (RT) refers to the repeated administration of small doses of radiation to a relatively large target, as in whole brain RT or focal (involved-field) RT. Fractionation of the total dose minimizes damage to normal tissues by allowing time for repair of damage to DNA and maximizes the killing of tumor cells. Conventional dose fractionation schemes for intracranial lesions typically consist of 1.8 to 2 Gy in daily sessions with cumulative doses of 30 to 60 Gy [1].


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Sep 8, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Chan A, Cardinale R, Loeffler J. Stereotactic irradiation. In: Perez CA, Brady LW, Halperin CA, Schmidt-Ullrich RK, Principles and practice of radiation oncology (Ed), Lippincott Williams & Wilkins, Philadelphia 2004.
  2. LEKSELL L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951; 102:316.
  3. Chan A, Cardinale R, Loeffler J. Stereotactic irradiation. In: Principles and practice of radiation oncology, Perez C, Brady L, Halperin E, Schmidt-Ullrich R (Eds), Lippincott Williams & Wilkins, Philadelphia 2004. p.410.
  4. Duma CM, Jacques D, Kopyov OV. The treatment of movement disorders using Gamma Knife stereotactic radiosurgery. Neurosurg Clin N Am 1999; 10:379.
  5. Barnett GH, Linskey ME, Adler JR, et al. Stereotactic radiosurgery--an organized neurosurgery-sanctioned definition. J Neurosurg 2007; 106:1.
  6. Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer 2004; 4:737.
  7. Saleh-Gohari N, Helleday T. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells. Nucleic Acids Res 2004; 32:3683.
  8. Kew Y, Levin VA. Advances in gene therapy and immunotherapy for brain tumors. Curr Opin Neurol 2003; 16:665.
  9. McDermott MW, Sneed PK. Radiosurgery in metastatic brain cancer. Neurosurgery 2005; 57:S45.
  10. Szeifert GT, Atteberry DS, Kondziolka D, et al. Cerebral metastases pathology after radiosurgery: a multicenter study. Cancer 2006; 106:2672.
  11. Chang SD, Adler JR Jr, Martin DP. LINAC radiosurgery for cavernous sinus meningiomas. Stereotact Funct Neurosurg 1998; 71:43.
  12. Nedzi LA, Kooy H, Alexander E 3rd, et al. Variables associated with the development of complications from radiosurgery of intracranial tumors. Int J Radiat Oncol Biol Phys 1991; 21:591.
  13. Phillips MH, Frankel KA, Lyman JT, et al. Comparison of different radiation types and irradiation geometries in stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 1990; 18:211.
  14. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000; 47:291.
  15. Leber KA, Berglöff J, Langmann G, et al. Radiation sensitivity of visual and oculomotor pathways. Stereotact Funct Neurosurg 1995; 64 Suppl 1:233.
  16. Leber KA, Berglöff J, Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998; 88:43.
  17. Ito K, Kurita H, Sugasawa K, et al. Analyses of neuro-otological complications after radiosurgery for acoustic neurinomas. Int J Radiat Oncol Biol Phys 1997; 39:983.
  18. Sakamoto T, Shirato H, Sato N, et al. Audiological assessment before and after fractionated stereotactic irradiation for vestibular schwannoma. Radiother Oncol 1998; 49:185.
  19. Stafford SL, Pollock BE, Leavitt JA, et al. A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2003; 55:1177.
  20. Tishler RB, Loeffler JS, Lunsford LD, et al. Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 1993; 27:215.
  21. Lunsford LD, Niranjan A, Flickinger JC, et al. Radiosurgery of vestibular schwannomas: summary of experience in 829 cases. J Neurosurg 2005; 102 Suppl:195.
  22. Eustacchio S, Trummer M, Fuchs I, et al. Preservation of cranial nerve function following Gamma Knife radiosurgery for benign skull base meningiomas: experience in 121 patients with follow-up of 5 to 9.8 years. Acta Neurochir Suppl 2002; 84:71.
  23. Kreil W, Luggin J, Fuchs I, et al. Long term experience of gamma knife radiosurgery for benign skull base meningiomas. J Neurol Neurosurg Psychiatry 2005; 76:1425.
  24. Muthukumar N, Kondziolka D, Lunsford LD, Flickinger JC. Stereotactic radiosurgery for jugular foramen schwannomas. Surg Neurol 1999; 52:172.
  25. Zhang N, Pan L, Dai JZ, et al. Gamma knife radiosurgery for jugular foramen schwannomas. J Neurosurg 2002; 97:456.
  26. Flickinger JC, Kondziolka D, Lunsford LD, et al. Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group. Int J Radiat Oncol Biol Phys 2000; 46:1143.
  27. Brown PD, Jaeckle K, Ballman KV, et al. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA 2016; 316:401.
  28. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009; 10:1037.
  29. Chapman PH, Ogilvy CS, Butler WE. A New Stereotactic Alignment System for Charged-Particle Radiosurgery at the Harvard Cyclotron Laboratory, Boston. In: Stereotactic Radiosurgery, Alexander III E, Loeffler JS, Lunsford LD (Eds), McGraw-Hill, New York 1993. p.105.
  30. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363:1665.
  31. Schwartz M. Stereotactic radiosurgery: comparing different technologies. CMAJ 1998; 158:625.
  32. Kuo JS, Yu C, Petrovich Z, Apuzzo ML. The CyberKnife stereotactic radiosurgery system: description, installation, and an initial evaluation of use and functionality. Neurosurgery 2003; 53:1235.
  33. Lawrence, E, Edlefsen, N. On the production of high speed protons. Science 1930; 72:376.
  34. Miller DW. A review of proton beam radiation therapy. Med Phys 1995; 22:1943.
  35. Sisterson J. Particle Therapy Co-Operative Group (PTCOG). Particles Newsletter 2005; 35.